Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the semaglutide.

GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and diarrhea) are practically common knowledge. But while many people expect some gastrointestinal discomfort on the meds,

On 60 Minutes this Sunday, the long term effects of Ozempic, plus more on Trump’s links to Jeffrey Epstein.

Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier

Earlier this month, it said it expects continued competition from copycat versions of its blockbuster obesity drug Wegovy this year and rising pressure from main U.S. rival, Eli Lilly. Novo said the new offer was part of its ongoing efforts to explore new collaborations and approaches towards improving access to authentic semaglutide medicines.